MEN 10376 [5051]
MEN 10376
| SMILES | CC(C)[C@H](NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(N)=O |
| InChIKey | QQHOFZNACVKNHK-SXVLBCBNSA-N |
| Sequence | DYWVWWK |
| HELM | PEPTIDE1{D.Y.[dW].V.[dW].[dW].K.[am]}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 11 |
| Hydrogen bond donors | 14 |
| Rotatable bonds | 28 |
| Log P | 2.088 |
| Molecular weight (Da) | 1080.5 |
| Stereochemistry info | unspecified |
Database connections
| Model (AF2) | NK2 |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
MEN 10376
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
| Model (AF2) | NK2 |